A.K. v. HHS - Meningococcal, IgA bullous dermatosis (2025)
Case summary [AI summaries can sometimes make mistakes]
On December 30, 2022, A.K. filed a petition alleging that meningococcal conjugate and meningococcal B vaccines administered on January 3, 2020 caused IgA bullous dermatosis. Respondent denied that the meningococcal vaccines caused A.K.'s skin disease or any vaccine-related sequelae.
The public stipulation does not describe the first rash or blistering symptoms, dermatology workup, biopsy or immunofluorescence findings, treatment, residual scarring, expert opinions, or the parties' competing medical theories. The parties resolved the case by stipulation.
A decision was originally filed on June 16, 2025, and the case was later refiled in redacted form after a privacy request. On September 26, 2025, the public redacted decision reflected an award of $95,000.00 as a lump sum through counsel's IOLTA account.
Theory of causation
Meningococcal conjugate and meningococcal B vaccines January 3, 2020 allegedly causing IgA bullous dermatosis; adult, exact age not stated; case refiled publicly in redacted form after privacy request. COMPENSATED by stipulation. Respondent denied causation and sequelae; public stipulation lacks rash/blister timeline, dermatology testing, biopsy/immunofluorescence, treatment, residuals, and expert theories. Award $95,000 lump sum. Chief SM Brian H. Corcoran; petition December 30, 2022; original decision June 16, 2025; public redacted decision September 26, 2025.